{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for the method of using biological products. The \"Independent Innovator and Repurposing Act\" allows for a 5-year extension of a patent for a method of using biological products, provided certain conditions are met. The \"Independent Innovator and Repurposing Act\" allows for a 5-year extension of a patent for a method of using biological products, if the patent term has not expired and has not been previously extended. To apply for the extension, the owner of the patent must submit an application to the Director containing the identity of the biological product. To extend a patent term under the \"Independent Innovator and Repurposing Act,\" the owner must submit an application to the Director with the biological product's identity, patent details, and proof that the patent was issued to an independent innovator. To extend a patent term under the \"Independent Innovator and Repurposing Act,\" the owner must provide the patent identity and details, along with proof that it was issued to an independent innovator or a qualified small business with ties to the innovator. To extend a patent term under the \"Independent Innovator and Repurposing Act,\" the owner must prove that the patent was issued to an independent innovator or a qualified small business with ties to the innovator, and that an application for commercial marketing of the biological product has been filed. The \"Independent Innovator and Repurposing Act\" allows for extending a patent term if certain conditions are met, including the filing of a commercial marketing application for a claimed method of use in the patent. Additionally, a minimum of 10 years must have passed between the submission of an exemption application for investigating the method of use and the FDA approval of the application. The curr_chunk discusses the requirements for an exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act for investigating a method of use, including the date of FDA approval. It also mentions the activities undertaken by the patent owner or agent related to the biological product during that period. The curr_chunk outlines the activities conducted by the patent owner or agent regarding the biological product and significant dates during the specified period for extension determination by the Director. The Director determines patent extension eligibility based on the application. If approved, a 5-year extension certificate is issued and recorded with the original patent. The Director issues a certificate of extension for 5 years if the requirements are met, which is recorded with the original patent. If the patent would expire before the extension is determined, the term is extended until a decision is made. The Director can extend the term of a patent for up to one year if an application for extension is pending and the patent is eligible. The term \"biological product\" is defined in this section. The Director can extend a patent for up to one year if eligible. Definitions include \"biological product\" and \"Director.\" The term \"Director\" refers to the Under Secretary of Commerce for Intellectual Property and Director of the US Patent and Trademark Office. An \"independent innovator\" is defined as a person or entity who obtains a method of use patent for a biological product and is not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act. An \"independent innovator\" obtains a method of use patent for a biological product and is not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act. The term \"affiliated\" in relation to the commercial marketing of a biological product refers to any employment, control, or common ownership relationship, whether direct or indirect. A \"qualified small business\" is defined as an entity with fewer than 500 employees, including affiliates, and not affiliated with the holder of the approved marketing application. The term \"qualified small business\" refers to an entity with fewer than 500 employees, not affiliated with the holder of the approved marketing application. This section will take effect on the enactment date and apply to any unexpired patent issued before or after that date."
}